1. Australian Institute of Health and Welfare. 2005. National Drug Strategy Household Survey 2004. Canberra: Australian Institute of Health and Welfare.

  2. Australian National Council on AIDS and Related Diseases. 1998. Estimating the number of injecting drug users in Australia using the Delphi technique. Sydney: National Centre in HIV Epidemiology and Clinical Research.

  3. Commonwealth of Australia. 2002. Return on investment in needle and syringe programs in Australia. Canberra: Commonwealth Department of Health and Ageing.

  4. Australian Medical Association. 2004. Position Statement: Blood borne viral infections. Canberra: Australian Medical Association.

  5. Aceijas, C., Stimson, G., Hickman, M. and Rhodes, T. 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 18: 2295-2303.

  6. McKetin, R., McLaren, J., Kelly, E., Hall, W. and Hickman, M. 2005. Estimating the number of regular and dependent methamphetamine users in Australia: Technical Report. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.

  7. Thein, H., Maher, L. and Dore, G. 2004. Illicit Drug Reporting System Drug Trends Bulletin October 2004. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.

  8. Commonwealth of Australia. 2004. National Drug Strategy - Australia's Integrated Framework: 2004-2009. Canberra: Australian Government Department of Health and Ageing.

  9. Ministerial Council on Drug Strategy. 1998. National Drug Strategic Framework 1998-99 to 2002-03. Building partnerships. A strategy to reduce the harm caused by drugs in our community. Canberra: Commonwealth of Australia.

  10. Feachem, R.G.A. 1995. Valuing the past ... Investing in the future. Evaluation of the National HIV/AIDS Strategy 1993-94 to 1995-96. Canberra: Australian Government Publishing Service.

  11. UNAIDS. 1999. Drug use and HIV/AIDS, UNAIDS Best Practice Collection Key Material. Geneva: UNAIDS. Top of page

  12. Commonwealth of Australia. 2005. National Hepatitis C Strategy 2005-2008. Canberra: Australian Government Department of Health and Ageing.

  13. Rowe, J. 2003. Who's using?: The Health Information Exchange [HIE] and the development of an innovative primary health care response for injecting drug users. Melbourne: Salvation Army Crisis Service.

  14. Wodak, A., Dolan, K.A., Imrie, A.A., Gold, J., Wolk, J., Whyte, B.M. and Cooper, D.A. 1987. Antibodies to human immunodeficiency virus in needles and syringes used by intravenous drug abusers. Medical Journal of Australia. 147: 275-276.

  15. Wolk, J., Wodak, A., Morlet, A., Guinan, J.J., Wilson, E., Gold, J. and Cooper, D. 1988. Syringe seroprevalence and behavioural and demographic characteristics of intravenous drug abusers using syringe exchanges in Sydney, Australia, 1987. AIDS. 2: 373-378.

  16. Dwyer, R., Fry, C., Carruthers, S., Bolleter, A., Dolan, K., Donald, A., Byrne, J. and Loxley, W. 2002. ABRIDUS: The Australian Blood-borne Virus Risk and Injecting Drug Use Study - A study of hepatitis C risk practices and contexts in Melbourne, Perth and Sydney. Melbourne: Turning Point Alcohol and Drug Centre Incorporated.

  17. New South Wales Department of Health. 2005.

  18. Obadia, Y., Feroni, I., Perrin, V., Vlahov, D. and Moatti, J.P. 1999. Syringe vending machines for injection drug users: an experiment in Marseille, France. American Journal of Public Health. 89(12): 1852-1854.

  19. Stark, K., Leicht, A. and Muller, R. 1994. Characteristics of users of syringe vending machines in Berlin. Sozial und Praventivmedizin. 39(4): 209-216.

  20. Wodak, A. and Cooney, A. 2004. Evidence for action technical papers: effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization.

  21. National Centre in HIV Epidemiology and Clinical Research. 2004. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2004. Canberra: National Centre in HIV Epidemiology and Clinical Research, Australian Institute of Health and Welfare.

  22. Crofts, N., Aitken, C.K. et al., 1999. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal of Australia. 170: 220-221.

  23. National Centre in HIV Epidemiology and Clinical Research. 2005. Australian NSP Survey, Prevalence of HIV, HCV and injecting and sexual behaviour among IDUs at Needle and Syringe Programs, National Data Report. Sydney: The University of New South Wales.

  24. MacDonald, M., Wodak, A.D., Ali, R., Crofts, N., Cunningham, P., Dolan, K., Kelaher, M., Loxley, W., van Beek, I. et al., 1997. HIV prevalence and risk behaviour in needle exchange attenders: A national study. Medical Journal of Australia. 166: 237-240.

  25. Strathdee, S.A., Patrick, D.M., Currie, S.L. 1997. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 11: F59-F65

  26. Lee, L., McKenna, M. and Sharpe, T. 2003. HIV diagnoses among injection-drug users in states with HIV surveillance - 25 states, 1994-2000. Morbidity and Mortality Weekly Report. 52(27): 634-636.

  27. Sydney Morning Herald. 1997. August 19, p15.

  28. Center for AIDS Prevention Studies. Does needle exchange work, University of California. Top of page

  29. Frischer, M. and Eliot, L. 1993. Discriminating needle exchange attenders from non-attenders. Addiction. 88: 681-687.

  30. Hankins, C., Gendron, S., Bruneau, J. and Roy, E. 1994. Evaluating Montreal's needle exchange CACTUS-Montreal, in Proceedings of the Workshop on Needle Exchange and Bleach Distribution Programs. Washington: National Academy Press, p83-90.

  31. Peak, A., Rana, S., Maharjan, S.H., Jolley, D. and Crofts, N. 1995. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: The impact of a harm reduction programme. AIDS. 9: 1067-1070.

  32. van Ameijden, E.J.C., van den Hoek, J.A.R., van Haastrecht, H.J.A. and Coutinho, R.A. 1992. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. American Journal of Epidemiology. 136: 236-243.

  33. Watters, J.K., Estilo, M.J., Clark, G.L. and Lorvick, J. 1994. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association. 271: 115-120.

  34. Crofts, N., Webb-Pullman, J. and Dolan, K. 1996. An analysis of trends over time in social and behavioural factors related to the transmission of HIV among IDUs and prison inmates. Evaluation of the National HIV/AIDS Strategy. Canberra: Australian Government Publishing Service.

  35. Broadhead, R.S., van Hulst, Y. and Heckathorn, D.D. 1999. Impact of the closure of a needle exchange program. Social Problems. 46(1): 48-66.

  36. MacDonald, M., Wodak, A., van Beek, I., Cunningham, P. et al., 2000. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Medical Journal of Australia. 172(2): 55-56.

  37. Australian Institute of Health and Welfare. 2003. Statistics on drug use in Australia 2002. Canberra: Australian Institute of Health and Welfare.

  38. World Health Organization. 2004. Evidence for action on HIV/AIDS and injecting drug use. Policy brief: Provision of sterile injecting equipment to reduce HIV transmission. Geneva: World Health Organization.

  39. Lines, R., Jurgens, R., Betteridge, G., Stover, H., Laticevschi, D. and Nelles, J. 2004. Prison needle exchange: Lessons from a comprehensive review of international evidence and experience. Montreal: Canadian HIV/AIDS Legal Network.

  40. Black, E., Dolan, K. and Wodak, A. 2004. Supply, demand and harm reduction strategies in Australian prisons: implementation, cost and evaluation. Research paper 9. Canberra: Australian National Council on Drugs.

  41. Darke, S. 1998. Self-report among injecting drug users: A review. Drug and Alcohol Dependence. 51: 253-263.

  42. Magura, S., Goldsmith, D., Casriel, C., Goldstein, P.J. and Lipton, D.S. 1987. The validity of methadone clients' self-reported drug use. International Journal of the Addictions. 22: 727-749.

  43. De Irala, J., Bigelow, C., McCusker, J., Hindin, R. and Zheng, L. 1996. Reliability of self-reported human immunodeficiency virus risk behaviours in a residential drug treatment population. American Journal of Epidemiology. 143: 725-731.

  44. Latkin, C., Vlahov, D. and Anthony, J.C. 1993. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 88: 517-526.

  45. Lurie, P. and Drucker, E. 1997. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 349: 604-608. Top of page

  46. Lurie, P., Reingold, A.L., Bowser, B. eds. 1993. The public health impact of needle exchange programs in the United States and abroad. San Francisco: University of California.

  47. Normand, J., Vlahov, D. and Moses, L.E. eds. 1995. Preventing HIV transmission: The role of sterile needles and bleach. Washington: National Academy Press.

  48. National Commission on Acquired Immune Deficiency Syndrome. 1991. The twin epidemics of substance use and HIV. Washington DC: National Commission on Acquired Immune Deficiency Syndrome.

  49. United States General Accounting Office. 1993. Needle exchange programs: Research suggests promise as an AIDS prevention strategy. Washington DC: House of Representatives.

  50. Office of Technology Assessment. 1995. The effectiveness of AIDS prevention efforts. Washington: Office of Technology Assessment.

  51. Hahn, J.A., Vranizan, K.M. and Moss, A.R. 1997. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 15: 157-164.

  52. Schechter, M.T., Strathdee, S.A., Cornelisse, P.G.A., Currie, S., Patrick, D.M., Rekart, M.L. and O'Shaughnessy, M.V. 1999. Do needle exchange programs increase the spread of HIV among injection drug users: An investigation of the Vancouver outbreak. AIDS. 13(6): F45-F51.

  53. Bruneau, J., Lamothe, F., Franco, E., Lachance, N., M, D., Soto, J. and Vinclette, J. 1997. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology. 146: 994-1002.

  54. Klee, H. and Morris, J. 1995. The role of needle exchanges in modifying sharing behaviour: Cross-study comparisons 1989-1993. Addiction. 90: 1635-1645.

  55. Stimson, G.V. 1989. Syringe exchange programmes for injecting drug users. AIDS. 3: 253-260.

  56. Carvell, A.M. and Hart, G.J. 1990. Help-seeking and referrals in a needle exchange: A comprehensive service to injecting drug users. British Journal of Addiction. 85: 235-240.

  57. Heimer, R., Kaplan, E.H., Khoshnood, K., Jariwala, B. and Cadman, E.C. 1993. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. American Journal of Medicine. 95: 214-220.

  58. Heimer, R. 1998. Can syringe exchange serve as a conduit to substance abuse treatment. Journal of Substance Abuse Treatment. 15(3): 183-191.

  59. Hagan, H., McGough, J.P., Thiede, H., Hopkins, S., Duchin, J. and Alexander, E.R. 2000. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment. 19(3): 247-52.

  60. Gibson, D.R. 2000. Two- to seven-fold decreased risk associated with use of needle exchange. In University of California 3rd annual Conference on AIDS Research in California, 17th Annual AIDS Investigators' Meeting. San Francisco.

  61. Wolk, J., Wodak, A., Guinan, J.J., Macaskill, P. and Simpson, J.M. 1990. The effect of a needle and syringe exchange on a methadone maintenance unit. British Journal of Addiction. 85: 1445-1450.

  62. Guydish, J., Bucardo, J., Young, M., Woods, W., Grinstead, O. and Clark, W. 1993. Evaluating needle exchange: Are there negative effects? AIDS. 7: 871-876.

  63. Hartgers, C., Buning, E.C., van Santen, G.W., Verster, A.D. and Coutinho, R.A. 1989. The impact of the needle and syringe-exchange program in Amsterdam on injecting risk behaviour. AIDS. 3(9): 571-576. Top of page

  64. van Ameijden, E.J. and Coutinho, R.A. 2001. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology & Community Health. 55(5): 356-363.

  65. Junge, B., Valente, T., Latkin, C., Riley, E. and Vlahov, D. 2000. Syringe exchange not associated with social network formation: results from Baltimore. AIDS. 14(4): 423-426.

  66. Bluthenthal, R.N., Gogineni, A., Longshore, D. and Stein, M. 2001. Factors associated with readiness to change drug use among needle exchange users. Drug & Alcohol Dependence. 62: 225-230.

  67. Bor, J. 1999. Needle programs no spur to crime. Baltimore Sun, p1B.

  68. Galea, S., Ahern, J., Fuller, C., Freudenberg, N. and Vlahov, D. 2001. Needle exchange programs and experience of violence in an inner city neighbourhood. Journal of Acquired Immune Deficiency Syndromes. 28(3): 282-288.

  69. Oliver, K.J., Friedman, S.R., Maynard, H., Magnuson, L. and Des Jarlais, D.C. 1992. Impact of a needle exchange program on potentially infectious syringes in public places. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 5: 534-535.

  70. Doherty, M.C., Garfein, R.S., Vlahov, D., Junge, B., Rathouz, P.J., Galai, N., Anthony, J.C. and Beilenson, P. 1997. Discarded needles do not increase soon after the opening of a needle exchange program. American Journal of Epidemiology. 145: 730-737.

  71. Doherty, M.C., Junge, B., Rathouz, P., Garfein, R.S., Riley, E. and Vlahov, D. 2000. The effect of needle exchange program on numbers of discarded needles: a 2-year follow-up. American Journal of Public Health. 90(6): 936-939.

  72. Department of Community and Health Services, personal communication. Tasmania.

  73. Queensland Department of Health. 1999. Report on the Queensland Needle Availability Support Program. Brisbane: Queensland Department of Health.

  74. Western Australia Department of Health. 2005.

  75. Bell, D. 1997. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. American Journal of Medicine. 102(5B): 9-15.

  76. Centers for Disease Control. 2001. Updated U.S. public health service guidelines for the management of occupational exposure to HBV, HCV and HIV and recommendations for post exposure prophylaxis. Morbidity and Mortality Weekly Report. 50(RR11): 1-42.

  77. Resnick, L., Vere, K., Salahuddin, S.Z., Tondreau, S. and Marham, P.D. 1986. Stability and inactivation of HTLV III/LAV under clinical and laboratory environments. Journal of the American Medical Association. 225: 1187-1191.

  78. Gaughwin, M.D., Gowans, E., Ali, R. and Burrell, C. 1991. Bloody needles: The volume of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS. 5: 1025-1027.

  79. Thompson, S., Boughton, C. and Dore, G. 2003. Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposure justified? Australian and New Zealand Journal of Public Health. 27(6): 602-607.

  80. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. 1997. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other blood-borne pathogens. Infection Control and Hospital Epidemiology. 18: 349-363.

  81. O'Leary, F. and Green, T. 2003. Community acquired needlestick injuries in non-health care workers presenting to an urban emergency department. Emergency Medicine Australasia. 15(5-6): 434-440. Top of page

  82. Russell, F. and Nash, M. 2002. A prospective study of children with community-acquired needlestick injuries in Melbourne. Journal of Paediatrics and Child Health. 38(2): 322.

  83. Libois, A., Fumero, E., Castro, P., Nomdedeu, M., Cruceta, A., Gatell, J.-M. and Garcia, F. 2005. Transmission of hepatitis C virus by discarded-needle injury. Clinical Infectious Diseases Journal. 41: 129-130.

  84. Fitzgerald, J.L., Broad, S. and Dare, A. 1999. Regulating the street heroin market in Fitzroy/Collingwood. Melbourne: University of Melbourne.

  85. Aitken, C., Moore, D., Higgs, P., Kelsall, J. and Kerger, M. 2002. The impact of a police crackdown on a street drug scene: evidence from the street. International Journal of Drug Policy. 13: 189-198.

  86. Maher, L. and Dixon, D. 2001. The cost of crackdowns: policing Cabramatta's heroin market. Current Issues in Criminal Justice. 13(1): 5-22.

  87. Burris, S., Vernick, J., Ditzler, A. and Strathdee, S. 2002. The legality of selling or giving syringes to injection drug users. Journal of American Pharmaceutical Association. 42(2): S13-18.

  88. Richard, A.J., Mosier, V. and Atkinson, J.S. 2002. New syringe acquisition and multi-person use of syringes among illegal drug users. Journal of Public Health Policy. 23(3): 324-343.

  89. American Psychiatric Association. 2003. Needle Exchange Programs Position Statement. American Psychiatric Association Operations Manual.

  90. Schechter, M., Strathdee, S.A., Cornelisse, P.G., Currie, S., Patrick, D.M., Rekart, M.L. and O'Shaughnessy, M.V. 1999. Do needle exchange programmes increase the spread of HIV among injection drug users: an investigation of the Vancouver outbreak. AIDS. 13(6): F45-51.

  91. Wodak, A., Strathdee, S.A., Friedman, S.R. and Byrne, J. 1998. The global response to the threat of HIV infection among and from injecting drug users. AIDS Targeted Information. 12: R41-R44.

  92. Lenton, S. 1994. Illicit drug use, harm reduction and the community: Attitudes to cannabis law and needle and syringe provision in Western Australia. Perth: National Centre for Research in to the Prevention of Drug Abuse.

  93. Schwartzkopf, J., Spooner, S., Flaherty, B., Braw, J., Grimsley, A., Scanlon, K. and Stewart, K. 1990. Community attitudes to needle and syringe exchange and to methadone programs. Sydney: New South Wales Department of Health.

  94. MacDonald, M., Rutter, S., Wodak, A. et al., 1999. K2 and Kings Cross community attitudes to the needle syringe program, discarded syringes and public injection, 1997 - 1998.Sydney: New South Wales Department of Health.

  95. The Lindesmith Centre. 1997. 71% of Americans Support Lifting Ban on Federal Funding for Needle Exchange Programs. Press release.

  96. Sydney Morning Herald. 1997. September 30, p8.

  97. UNAIDS, Health Canada, Open Society Institute and Canadian International Development Agency. 2003. The Warsaw Declaration: A Framework for Effective Action on HIV/AIDS and Injecting Drug Use. In Second International Policy Dialogue on HIV/AIDS. Warsaw, Poland.